Handa Pharmaceuticals, Inc. Announces Launch of Proprietary ONCORE™ Oncology Drug Delivery Technology Platform

Tainan City, Taiwan, July 17, 2018 —  Handa Pharmaceuticals, Inc. (Taiwan Exchange: 6620) (“Handa”), a specialty pharmaceutical company focusing on the research, development and commercialization of innovative prescription drugs in the fields of neuroscience and oncology, today announced the launch of its proprietary ONCORE™ oncology drug delivery technology platform. The Company’s proprietary ONCORE™ technology platform will [...]